Abstract
Interleukin (IL)-33 protects against infection and inflammation; however, few studies have explored the relevance of IL-33 in lung cancer patients. We evaluated relation of plasma IL-33 levels with development and progression of lung cancer. A total of 160 patients with lung cancer and 160 controls with normal lungs were enrolled. Plasma IL-33 levels were measured using a specific sandwich ELISA; these levels were followed-up in 18 patients who underwent surgery and in 14 patients treated with chemotherapy. Malignant lesions and normal lung tissues from 10 cancer patients were subjected to immunohistochemical staining for IL-33. IL-33 levels were significantly lower in cancer patients than normal controls (0.08 vs. 0.38 ng/mL, p=0.005). Among cancer patients, IL-33 decreased in a stage-dependent manner from 0.76 ng/mL in stage I patients to 0.25 ng/mL in those with stage II, 0.08 ng/mL in those with stage III, and 0.08 ng/mL in those with stage IV (p=0.002). The levels were higher at stage I (p=0.041) and markedly lower at stages III and IV than those of controls (p=0.005 and p=0.001, respectively). A similar pattern was observed when IL-33 levels were analyzed by T stage; the levels were 0.39 ng/mL at T1/T2 vs. 0.08 ng/mL at T...Continue Reading
References
Nov 24, 1999·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H OndaJ Takeda
Jun 24, 2003·The American Journal of Pathology·Espen S BaekkevoldJean-Philippe Girard
Nov 16, 2005·Immunity·Jochen SchmitzRobert A Kastelein
Sep 1, 2007·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Peter GoldstrawUNKNOWN Participating Institutions
Sep 14, 2007·European Journal of Immunology·Mousa Komai-KomaFoo Y Liew
Jun 14, 2008·International Immunology·Molly D SmithgallDirk E Smith
Aug 1, 2008·Proceedings of the National Academy of Sciences of the United States of America·Damo XuFoo Y Liew
Oct 7, 2008·PloS One·Christine MoussionJean-Philippe Girard
Nov 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kenichi KoyamaFumitake Gejyo
Mar 31, 2009·Nature Medicine·Hamida HammadBart N Lambrecht
Jan 28, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alessandra Mancino, Toby Lawrence
Apr 13, 2011·European Journal of Immunology·Ivan JovanovicMiodrag L Lukic
Feb 11, 2012·Science·Weldy V BonillaDaniel D Pinschewer
Mar 7, 2012·Immunologic Research·Marija MilovanovicMiodrag L Lukic
Jun 22, 2012·Oncoimmunology·Ivan P JovanovicMiodrag L Lukic
Jul 24, 2012·Cytokine·Annett SchmiederJürgen Radons
Sep 11, 2012·Trends in Immunology·Liying GuoWilliam E Paul
Mar 19, 2013·Cancer Letters·Kun GaoLianfeng Zhang
Jun 4, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Liang-An HuJie Zhang
Jan 23, 2014·Cancer Research·Daniel O VillarrealDavid B Weiner
Citations
Mar 24, 2016·European Journal of Immunology·Christian SchwartzPadraic G Fallon
Sep 21, 2016·Biochemical and Biophysical Research Communications·Chunhong WangWeiqing Song
May 3, 2018·International Journal of Cancer. Journal International Du Cancer·Hong-Tai TzengYi-Ching Wang
Mar 24, 2018·Oncotarget·Mengyao SunChunye Ma
Apr 13, 2017·Oncotarget·Wenwei HuChangping Wu
Jun 23, 2020·Oncology Letters·Michał PudereckiBarbara Marzec-Kotarska
Dec 3, 2016·Cold Spring Harbor Molecular Case Studies·Stefan GröschelStefan Fröhling
Sep 13, 2018·International Journal of Molecular Sciences·Kristen M LarsenMaria Marjorette O Peña
Jan 7, 2017·Medical Oncology·Yujiang FangMichael B Nicholl
May 26, 2018·Journal of Cellular and Molecular Medicine·Jun-Li WangYu-Jin Tang
Jul 12, 2018·Cancer Biomarkers : Section a of Disease Markers·Razieh ZareAzadeh Andishe-Tadbir
May 28, 2019·Biomolecules·Marco CasciaroSebastiano Gangemi
Feb 1, 2020·Oncoimmunology·Byung-Seok KimSeon Hee Chang
Oct 6, 2020·Frontiers in Oncology·Ting LanPing Ma
Nov 13, 2018·Frontiers in Immunology·Jean-Jacques Fournié, Mary Poupot
Oct 28, 2019·International Journal of Molecular Sciences·Alessandro AllegraSebastiano Gangemi
Jan 12, 2019·Frontiers in Immunology·Dev Karan
Jun 25, 2019·Frontiers in Immunology·Kevin J BakerElizabeth Brint
Nov 15, 2018·Medical Oncology·Markus KielerGerald W Prager
Nov 30, 2018·Frontiers in Immunology·Claudia AfferniGiovanna Schiavoni
Oct 25, 2020·Cancer Science·Satoshi NagaokaMasaki Mori
Oct 17, 2020·BioMed Research International·Xiaolan PanMin Fang
Jul 3, 2021·Cancers·Mi-Ran ChoiBin Zhang
Sep 11, 2021·Frontiers in Immunology·Tobias BurkardHeinfried H Radeke